Medical Xpress·3 min read·medium
Newer insulin may reduce low blood sugar in youth with type 1 diabetes
U
University of Pittsburgh Schools of the Health Sciences
✦AI Summary
A clinical trial involving youth with type 1 diabetes in Bangladesh and Tanzania found that the insulin analog glargine reduced nighttime hypoglycemia compared to older human insulins. These benefits, however, were only observed after one year of treatment.
Why it matters
The findings provide critical evidence for healthcare policy decisions regarding insulin access and treatment standards in low-resource settings.
by University of Pittsburgh Schools of the Health Sciences
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
The report summarizes scientific findings from a peer-reviewed study without bias.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in